Tag: Ssc ild

Idiopathic pulmonary fibrosis (IPF) affects 13 to 20 per 100,000 people worldwide [1.10.1, 1.10.5]. For those diagnosed, a key question is: is nintedanib long term use a viable strategy? The evidence points to yes, as it is designed for chronic disease management.

In clinical trials like INPULSIS and INBUILD, over 60% of patients taking nintedanib reported experiencing diarrhea, making it the most common adverse event associated with the medication [1.2.1, 1.8.5]. The question is not just *if*, but how to manage when it occurs. So, **can nintedanib cause diarrhea?** The answer is a definitive yes.

Tocilizumab is a biologic medication that blocks the inflammatory protein interleukin-6 (IL-6), and its approval for treating various conditions, such as rheumatoid arthritis, has transformed patient care. So, **what is tocilizumab used to treat?** This powerful medication has several key applications, leveraging its ability to modulate the immune response and reduce severe inflammation.